适应性共组装的基于硫丁/氨酸的抗炎药物载体,可注射和可控制释放
Qin Li1, Aoli Wu1, Mengqi Zhang1
1NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, China.
International journal of biological macromolecules
|November 3, 2024
概括
研究人员开发了基于蒂莫丁 (TP5) 的载体颗粒 (TGCP) 用于长期药物输送. 这些生物相容的载体表现出协同的抗炎作用和多种药物的受控释放,减少像IL-6这样的炎症因素.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性疾病需要长期的治疗策略.
- 开发具有抗炎性能的有效药物输送系统至关重要.
- 从单个载体中控制释放多种药物仍然是一个挑战.
研究的目的:
- 使用动态共价组装方法制造基于蒂莫丁 (TP5) 的载体颗粒 (TGCP).
- 调查TGCP的抗炎潜力和药物递送能力.
- 评估TGCP与氨酸 (HA) 在慢性疾病管理中的协同效应.
主要方法:
- 基于TP5的载体颗粒 (TGCP) 通过动态共价组合的制造.
- 使用 Hyaluronic 酸 (HA) 调节 TGCP 尺寸和分散性.
- 载入各种客分子并评估受控释放配置文件.
- 通过在体外测量IL-6水平来评估抗炎活性.
主要成果:
- TGCP表现出生物相容性和自身光.
- HA调节TGCP的大小和分散性,增强注射性和协同抗炎活性.
- TGCP成功加载了多种分子,并证明了控制的梯度释放.
- 装载着传统中医药的TGCP/HA有效降低了IL-6水平.
结论:
- 基于TP5/HA的材料具有出色的载体特性和免疫活性.
- 这些材料有望减少疾病部位的炎症.
- 开发的系统显示了在慢性疾病中长期药物输送的潜力.
相关概念视频
Drug Delivery: Miscellaneous Routes
329
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
329
Drug Delivery: Parenteral Route
431
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
431
Insulin Formulations: Types and Delivery
169
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
169


